RPL17 and neoplasm: The aggregate of plasmid DNA encoding ovalbumin (OVA) (referred to as pOVA) vaccine with pVAX-α-PD-1 caused enormous tumor regression, which is often attributed to the elevated cytokine stage and proportion of CD8+ T and CD4+ T cells in tumors.